On serotonin and experimental anxiety

Psychopharmacology

Volumn 163, Issue 3-4, 2002, Pages 467-476

  Graeff, Frederico G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amygdala; Aversion; Defensive reaction; Generalized anxiety; Panic; Periaqueductal gray; Punishment; Septo hippocampal system; Serotonin

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CLOMIPRAMINE; DEXFENFLURAMINE; DIAZEPAM; EPLIVANSERIN; FANANSERIN; IMIPRAMINE; IPSAPIRONE; MOCLOBEMIDE; RITANSERIN; SER 082; SEROTONIN; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; YOHIMBINE;

ANXIETY; CONDITIONING; ELECTROSTIMULATION; ESCAPE BEHAVIOR; FOREBRAIN; LEARNING; MAZE TEST; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PIGEON; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; COLUMBIDAE; CONFLICT (PSYCHOLOGY); DEFENSE MECHANISMS; ESCAPE REACTION; MAZE LEARNING; MODELS, PSYCHOLOGICAL; PERIAQUEDUCTAL GRAY; PUNISHMENT; SEROTONIN; SEROTONIN AGENTS;

EID: 0036392318     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1112-4     Document Type: Review

References (89)

1. Aghajanian GK (1992) Central 5-HT receptor subtypes: physiological responses and signal transduction mechanisms. In: Marsden CA, Heal DJ (eds) Central serotonin receptors and psychotropic drugs. Blackwell, Oxford, pp 39-55
2. Amano K, Tanikawa T, Iseki H, Notani M, Kawamura H, Kitamura K (1978) Single neuron analysis of the human midbrain tegmentum. Appl Neurophysiol 41:66-78
3. American Psychiatry Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. APA Press, Washington D.C.
4. Argyropoulos SV, Sandford JJ, Nutt DJ (2000) The psychobiology of anxiolytic drug. Part 2: pharmacological treatments of anxiety. Pharmacol Ther 88:213-227
5. Audi EA, de Oliveira RMW, Graeff FG (1991) Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plusmaze antagonized by rita-nserin. Psychopharmacology 105:553-557
6. Azmitia EC, Segal M (1978) An autodiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-688
7. 3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Wiley, Chichester, pp 59-105
8. 1A receptors antagonist WAY 100635 on periaqueductal grey-induced defence behaviour. J Psychopharmacol 11:35-40
9. 1 receptor agonists administered into the periaqueductal gray. Psychopharmacology 108:110-114
10. Blanchard DC, Blanchard RJ (1988) Ethoexperimental approaches to the biology of emotion. Annu Rev Psychol 39:43-68
11. Blanchard DC, Griebel G, Blanchard RJ (2001) Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 25:205-218
12. Bourin M, Baker GB, Bradwejn J (1998) Neurobiology of panic disorder. J Psychosom Res 44:163-180
13. Bradwejn J, Koszycki D, Meterissian G (1990) Chlecystokinintetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35:83-85
14. Brandão ML, de Aguiar JC, Graeff FG (1982) GABA mediation of the anti-aversive action of minor tranquilizers. Pharmacol Biochem Behav 16:397-402
15. Costa E, Guidotti A (1979) Molecular mechanisms in the receptor action of benzodiazepines. Annu Rev Pharmacol Toxicol 19:531-545
16. Davis M (1992) The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15:353-375
17. Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defence. J Psychopharmacol 5:305-315
18. Delgado JMR, Roberts WW, Miller NE (1954) Learning motivated by electrical stimulation of the brain. Am J Physiol 179:587-593
19. Eison AS, Temple DL (1989) Buspirone: review of its pharmacology and current perspectives on the mechanism of action. Am J Med 80:1-9
20. Estes WK, Skinner FB (1941) Some quantitative properties of anxiety. J Exp Psychol 29:390-400
21. Fanselow MS (1991) The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. In: Depaulis A, Bandler R (eds) The midbrain periaqueductal gray matter: functional, anatomical and immunohistochemical organization. Plenum, New York, pp 151-173
22. File SR, Zangrossi H Jr, Viana MB, Graeff FG (1993) Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology 111:491-494
23. Geller I, Seifter J (1960) The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482-492
24. Gentil V (1988) The aversive system, 5HT and panic attacks. In: Simon P, Soubrié P, Willocher D (eds) Animal models of psychiatric disorders, vol 1. Karger, Basel, pp 142-145
25. Gentil V, Lotufo-Neto F, Andrade L, Cordás T, Bernik M, Ramos R, Maciel L, Miyakawa E, Gorenstein C (1993) Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine. J Psycho-pharmacol 7:316-324
26. Graeff FG (1974) Tryptamine antagonists and punished behavior. J Pharmacol Exp Ther 189:344-350
27. Graeff FG (1981) Minor tranquilizers and brain defense systems. Braz J Med Biol Res 14:239-265
28. Graeff FG (1988) Animal model of aversion. In: Simon P, Soubrié P, Willocher D (eds) Animal models of psychiatric disorders, vol 1. Karger, Basel, pp 115-141
29. Graeff FG (1990) Brain defense systems and anxiety. In: Roth M, Burrows GD, Noyes R (eds) Handbook of anxiety, vol 3. The neurobiology of anxiety. Elsevier, Amsterdam, pp 307-354
30. Graeff FG (1994) Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Brazil J Med Biol Res 27:811-829
31. Graeff FG, Rawlins JNP (1980) Dorsal periaqueductal gray punishment, septal lesions and the mode of action of minor tranquilizers. Pharmacol Biochem Behav 12:41-45
32. Graeff FG, Schoenfeld RI (1970) Tryptaminergic mechanisms in punished and nonpunished behavior. J Pharmacol Exp Ther 173:277-283
33. Graeff FG, Silveira Filho NG (1978) Behavioral inhibition induced by electrical stimulation of the median raphe nucleus of the rat. Physiol Behav 21:477-484
34. Graeff FG (1991) Neurotransmitters in the dorsal periaqueductal gray and animal models of panic anxiety. In: Briley M, File SE (eds) New concepts in anxiety. MacMillan, London, pp 288-312
35. Graeff FG, Viana MB, Tomaz C (1993) The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Brazil J Med Biol Res 26:67-70
36. Graeff FG, Viana MB, Mora PO (1996a) Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze. Pharmacol Biochem Behav 53:171-177
37. Graeff FG, Viana MB, Mora PO (1996b) Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 54:129-141
38. Graeff FG, Guimar̃es FS, de Andrade TGCS, Deakin JFW (1996c) Role of 5-HT in stress, anxiety and depression. Pharmacol Biochem Behav 54:129-141
39. Graeff FG, Ferreira Netto C, Zangrossi H Jr (1998) The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23:237-246
40. Graeff FG, Silva M, Del-Ben CM, Zuardi AW, Hetem LA, Guimar̃es FSG (2001) Comparison between two models of experimental anxiety in healthy volunteers and panic disorder patients. Neurosci Biobehav Rev 25:753-759
41. Gray JA (1982) The neuropsychology of anxiety. Oxford University Press, New York
42. Gray JA, McNaughton N (2000) The neuropsychology of anxiety. Oxford University Press, Oxford
43. Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395
44. Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists in a maze-exploration model of "fear"-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1-5
45. Handley SL, McBlane JW, Critchley MAE, Njung'e K (1993) Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav Brain Res 58:203-210
46. Hetem LAB (1995) Addition of d-fenfluramine to benzodiazepines produced a marked improvement in refractory panic disorder - a case report. J Clin Psychopharmacol 16:77-78
47. Hodges H, Green S, Glenn B (1987) Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not in discrimination. Psychopharmacology 92:491-504
48. Hunsperger RW (1956) Affektreaktionen und elektrische Reizung im Hirnstam der Katze. Helvet Physiol Pharmacol Acta 14:70-92
49. 1C) receptors on periaqueductal gray aversion. Eur J Pharmacol 161:219-221
50. Jenck F, Broekkamp CLE, van Delft AML (1990) The effect of antidepressants on aversive PAG stimulation. Eur J Pharmacol 177:201-204
51. Kahn RJ, MacNair DM, Lipman RS, Covi L, Rickels K, Downing R, Fischer S, Grankenthaler LM (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients. Arch Gen Psychiatry 43:79-85
52. Kiser RS Jr, Lebovitz RM (1975) Monoaminergic mechanisms in aversive brain stimulation. Physiol Behav 15:47-53
53. Kiser RS, German DC, Lebovitz RM (1978a) Serotonergic reduction of dorsal central gray area stimulation-produced aversion. Pharmacol Biochem Behav 9:27-31
54. Kiser RS Jr, Lebovitz RM, German DC (1978b) Anatomic and pharmacologic differences between two types of aversive midbrain stimulation. Brain Res 155:331-342
55. Kiser RS, Brown CA, Sanghera MK, German DC (1980) Dorsal raphe nucleus stimulation reduces centrally-elicited fearlike behavior. Brain Res 191:265-72
56. Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions. Arch Gen Psychiatry 50:306-317
57. Klein DF, Flink M (1962) Psychiatric reaction patterns to imipramine. J Psychiatry 119:432-438
58. LeDoux JE (1993) Emotional memory systems in the brain. Behav Brain Res 58:69-79
59. Lovick TA (2000) Panic disorder - a malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter? Neuroscientist 6:48-59
60. Mamounas LA, Mullen CA, O'Hearn E, Molliver ME (1991) Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314:558-586
61. McBlane JW, Handley SL (1994) Effects of two stressors on behavior in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT. Psychopharmacology 116:173-182
62. Michelson D, Pollack M, Lydiard RB, Tamura R, Tepner R, Tollefson G (1999) Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group. Br J Psychiatry 174:213-218
63. Millenson JR, Leslie J (1974) The conditioned emotional response (CER) as a baseline for the study of anti-anxiety drugs. Neuropharmacology 13:1-9
64. Montgomery KC (1955) The relationship between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 48:254-260
65. Morato de Carvalho S, de Aguiar JC, Graeff FG (1981) Effect of minor tranquilizers, tryptamine antagonists and amphetamine on behavior punished by brain stimulation. Pharmacol Biochem Behav 15:351-356
66. Mortimore C, Anderson IM (2000) d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine. Psychopharmacology 149:251-258
67. Nashold BS Jr, Wilson NP, Slaughter GS (1974) The midbrain and pain. In: Bonica JJ (ed) Advances in neurology, vol 4: international symposium on pain. Raven Press, New York, pp 191-196
68. Nogueira RL, Graeff FG (1991) Mediation of the antiaversive effect of isamoltane injected into the dorsal periaqueductal grey. Behav Pharmacol 2:73-77
69. Nogueira RL, Graeff FG (1995) Role of 5-HT receptor subtypes in the modulation of aversion generated in the dorsal periaqueductal gray. Pharmacol Biochem Behav 52:1-6
70. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in the elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167
71. Petersen EN, Scheel-Krüger J (1984) Anticonflict effects of 5-HT antagonists by intraamygdaloid injection. Abstracts of the 14th CINP Congress, p 654
72. Robichaud RC, Sledge KL (1969) The effects of p-chlorophenylalanine on experimentally induced conflict in the rat. Life Sci 8:965-969
73. Schenberg LC, Graeff FG (1978) Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines. Pharmacol Biochem Behav 9:287-295
74. Schoenfeld RI (1976) Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat. Science 192:801-803
75. Schütz MTB, de Aguiar JC, Graeff FG (1985) Anti-aversive role of serotonin on the dorsal periaqueductal grey matter. Psychopharmacology 85:340-345
76. Series HG, Cowen PJ, Sharp T (1994) p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology 116:508-514
77. Silveira MCL, Zangrossi H Jr, Viana MB, Silveira R, Graeff FG (2001) Differential expression of Fos protein in the rat brain induced by performance of avoidance or escape in the elevated T-maze. Behav Brain Res 126:13-21
78. Solyom L (1994) Controlling panic attacks with fenfluramine. Am J Psychiatry 151:621-622
79. Targum SD, Marshall LE (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 28:295-306
80. Teixeira RC, Zangrossi Junior H, Graeff FG (2000) Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol Biochem Behav 65:571-576
81. Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463-469
82. Tye NC, Everitt BJ, Iversen SD (1977) 5-Hydroxytryptamine and punishment. Nature 268:741-742
83. Vargas LC, Schenberg LC (2001) Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat. Psychopharmacology 155:260-268
84. Viana MB, Tomaz C, Graeff FG (1994) The elevated T maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 49:549-554
85. Viana MB, Silveira R, Graeff FG (1996) D-fenfluramine releases 5-HT from terminals of the dorsal raphe nucleus. Brazil J Med Biol Res 29:639-642
86. Wise CD, Berger BD, Stein L (1972) Benzodiazepines: Anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 177:180-183
87. Wuttke W, Kelleher RT (1970) Effects of some benzodiazepines on punished and unpunished behavior in the pigeon. J Pharmacol Exp Ther 172:397-405
88. Zangrossi H Jr, Graeff FG (1997) Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull 44:1-5
89. Zangrossi H Jr, Viana MB, Zanoveli J, Bueno C, Nogueira RL, Graeff FG (2001) Serotonergic regulation of inhibitory avoidance and one-way escape in the elevated T-maze. Neurosci Biobehav Rev 25:637-645